Related Experiment Videos
Klion in the prevention of early complications following appendectomy
H Hájková1, M Prichlik, M Bártová
1Department of Paediatric Surgery, Thomayer's Teaching Hospital, Prague.
Insights
Prophylactic administration of metronidazole (Klion) in children with phlegmonous appendicitis demonstrated excellent results, preventing inflammatory complications. This study highlights Klion as a safe and effective prophylactic agent in pediatric appendicitis cases.
Area of Science:
- Pediatric Surgery
- Infectious Diseases
- Pharmacology
Background:
- Phlegmonous appendicitis in children can lead to significant inflammatory complications.
- Prophylactic antibiotic use is a key strategy to mitigate surgical site infections.
Purpose of the Study:
- To evaluate the efficacy of prophylactic metronidazole (Klion) in preventing complications of phlegmonous appendicitis in children.
- To assess the safety and tolerability of metronidazole for this indication.
Main Methods:
- A cohort of 51 children with phlegmonous appendicitis received prophylactic metronidazole (Klion).
- Bacteriological assessments were performed in 42 children.
- Complication rates were compared to a historical cohort of 1,008 children without prophylaxis.
Main Results:
- Excellent outcomes were observed with prophylactic Klion, with zero inflammatory wounds or intraperitoneal complications in the treated group.
- The complication rate in the non-prophylaxis group was 3.62%.
- Metronidazole (Klion) exhibited minimal side effects and was well tolerated.
Conclusions:
- Prophylactic metronidazole (Klion) is highly effective in preventing inflammatory complications in pediatric phlegmonous appendicitis.
- Klion is a safe, well-tolerated, and superb option for prophylaxis in this patient population.
Abstract:
The authors observations with prophylactic administration of metronidazole manufactured by the Gedeon Richter Company, Hungary (trade mark Klion) in children with phlegmonous appendicitis are reported. The drug was administered in three doses to 51 children. Results of bacteriology could be assessed in 42 children. The results of prophylactic administration of Klion in phlegmonous appendicitis were excellent. In our group there were no inflammatory wounds and/or intraperitoneal complications. For comparison, in a cohort of 1.008 children with phlegmonous appendicitis, without prophylaxis the rate of inflammatory complications was 3.62%. Klion has minimal side effects and is well tolerated and seems to be a superb drug for prophylaxis.